Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.0
(1.17%)
CNY 13.0
(1.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 669.29 Million CNY | 3.05% |
| 2022 | 634.26 Million CNY | 33.81% |
| 2021 | 473.99 Million CNY | -9.22% |
| 2020 | 522.13 Million CNY | -19.67% |
| 2019 | 650.02 Million CNY | 6.96% |
| 2018 | 607.73 Million CNY | 8.95% |
| 2017 | 557.79 Million CNY | 17.43% |
| 2016 | 474.98 Million CNY | 42.38% |
| 2015 | 333.59 Million CNY | 22.77% |
| 2014 | 271.73 Million CNY | 4.72% |
| 2013 | 259.48 Million CNY | 12.74% |
| 2012 | 230.15 Million CNY | 20.81% |
| 2011 | 190.51 Million CNY | 65.04% |
| 2010 | 115.43 Million CNY | 54.17% |
| 2009 | 74.87 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 128.03 Million CNY | -46.12% |
| 2024 Q3 | 131.75 Million CNY | 2.9% |
| 2024 Q1 | 237.64 Million CNY | 47.78% |
| 2023 Q1 | 170.61 Million CNY | -18.76% |
| 2023 Q3 | 178.45 Million CNY | 2.77% |
| 2023 Q2 | 173.63 Million CNY | 1.77% |
| 2023 FY | 653.6 Million CNY | 3.05% |
| 2023 Q4 | 160.8 Million CNY | -9.89% |
| 2022 Q3 | 157.03 Million CNY | 7.06% |
| 2022 Q2 | 146.68 Million CNY | 21.69% |
| 2022 FY | 634.26 Million CNY | 33.81% |
| 2022 Q4 | 210.02 Million CNY | 33.74% |
| 2022 Q1 | 120.53 Million CNY | -14.15% |
| 2021 Q2 | 109.43 Million CNY | -0.87% |
| 2021 Q1 | 110.39 Million CNY | 7.14% |
| 2021 FY | 473.99 Million CNY | -9.22% |
| 2021 Q4 | 140.4 Million CNY | 23.43% |
| 2021 Q3 | 113.75 Million CNY | 3.94% |
| 2020 Q2 | 163.38 Million CNY | 49.39% |
| 2020 Q4 | 103.04 Million CNY | -29.58% |
| 2020 Q3 | 146.33 Million CNY | -10.43% |
| 2020 FY | 522.13 Million CNY | -19.67% |
| 2020 Q1 | 109.36 Million CNY | -36.46% |
| 2019 Q4 | 172.11 Million CNY | 8.11% |
| 2019 FY | 650.02 Million CNY | 6.96% |
| 2019 Q3 | 159.2 Million CNY | -5.0% |
| 2019 Q2 | 167.59 Million CNY | 10.91% |
| 2019 Q1 | 151.1 Million CNY | -12.09% |
| 2018 Q2 | 158.94 Million CNY | 25.82% |
| 2018 Q1 | 126.32 Million CNY | -23.51% |
| 2018 FY | 607.73 Million CNY | 8.95% |
| 2018 Q4 | 171.89 Million CNY | 14.15% |
| 2018 Q3 | 150.57 Million CNY | -5.26% |
| 2017 FY | 557.79 Million CNY | 17.43% |
| 2017 Q1 | 102.69 Million CNY | -32.24% |
| 2017 Q2 | 149.35 Million CNY | 45.43% |
| 2017 Q3 | 140.59 Million CNY | -5.86% |
| 2017 Q4 | 165.14 Million CNY | 17.46% |
| 2016 Q3 | 115.2 Million CNY | -5.81% |
| 2016 FY | 474.98 Million CNY | 42.38% |
| 2016 Q1 | 85.9 Million CNY | -32.81% |
| 2016 Q2 | 122.31 Million CNY | 42.39% |
| 2016 Q4 | 151.55 Million CNY | 31.55% |
| 2015 Q3 | 81 Million CNY | 16.55% |
| 2015 Q4 | 127.84 Million CNY | 57.83% |
| 2015 Q2 | 69.49 Million CNY | 25.79% |
| 2015 Q1 | 55.24 Million CNY | -35.09% |
| 2015 FY | 333.59 Million CNY | 22.77% |
| 2014 Q2 | 66.78 Million CNY | 32.53% |
| 2014 Q1 | 50.39 Million CNY | -34.4% |
| 2014 Q4 | 85.11 Million CNY | 22.57% |
| 2014 Q3 | 69.44 Million CNY | 3.98% |
| 2014 FY | 271.73 Million CNY | 4.72% |
| 2013 Q3 | 68.97 Million CNY | 0.0% |
| 2013 FY | 259.48 Million CNY | 12.74% |
| 2013 Q4 | 76.82 Million CNY | 11.38% |
| 2012 FY | 230.15 Million CNY | 20.81% |
| 2011 FY | 190.51 Million CNY | 65.04% |
| 2010 FY | 115.43 Million CNY | 54.17% |
| 2009 FY | 74.87 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 4.15 Billion CNY | 83.881% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.72 Billion CNY | 75.415% |
| Beijing Strong Biotechnologies, Inc. | 1.3 Billion CNY | 48.53% |
| Medicalsystem Biotechnology Co., Ltd. | 834.37 Million CNY | 19.784% |
| Maccura Biotechnology Co.Ltd | 1.51 Billion CNY | 55.721% |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.72 Billion CNY | 61.189% |
| Guangdong Hybribio Biotech Co.,Ltd. | 662.35 Million CNY | -1.049% |
| BGI Genomics Co., Ltd. | 2.17 Billion CNY | 69.165% |
| Amoy Diagnostics Co., Ltd. | 871.54 Million CNY | 23.205% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 329.31 Million CNY | -103.24% |